Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5T4S

Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors

5T4S の概要
エントリーDOI10.2210/pdb5t4s/pdb
分子名称Renin, 2-acetamido-2-deoxy-beta-D-glucopyranose, 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE, ... (7 entities in total)
機能のキーワードprotein-ligand complex, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Homo sapiens (Human)
細胞内の位置Secreted: P00797
タンパク質・核酸の鎖数2
化学式量合計75532.52
構造登録者
Snell, G.P.,Behnke, C.A.,Okada, K.,Oki, H.,Sang, B.C.,Lane, W. (登録日: 2016-08-30, 公開日: 2016-10-26, 最終更新日: 2024-11-06)
主引用文献Tawada, M.,Suzuki, S.,Imaeda, Y.,Oki, H.,Snell, G.,Behnke, C.A.,Kondo, M.,Tarui, N.,Tanaka, T.,Kuroita, T.,Tomimoto, M.
Novel approach of fragment-based lead discovery applied to renin inhibitors.
Bioorg.Med.Chem., 24:6066-6074, 2016
Cited by
PubMed Abstract: A novel approach was conducted for fragment-based lead discovery and applied to renin inhibitors. The biochemical screening of a fragment library against renin provided the hit fragment which showed a characteristic interaction pattern with the target protein. The hit fragment bound only to the S1, S3, and S3 (S3 subpocket) sites without any interactions with the catalytic aspartate residues (Asp32 and Asp215 (pepsin numbering)). Prior to making chemical modifications to the hit fragment, we first identified its essential binding sites by utilizing the hit fragment's substructures. Second, we created a new and smaller scaffold, which better occupied the identified essential S3 and S3 sites, by utilizing library synthesis with high-throughput chemistry. We then revisited the S1 site and efficiently explored a good building block attaching to the scaffold with library synthesis. In the library syntheses, the binding modes of each pivotal compound were determined and confirmed by X-ray crystallography and the library was strategically designed by structure-based computational approach not only to obtain a more active compound but also to obtain informative Structure Activity Relationship (SAR). As a result, we obtained a lead compound offering synthetic accessibility as well as the improved in vitro ADMET profiles. The fragments and compounds possessing a characteristic interaction pattern provided new structural insights into renin's active site and the potential to create a new generation of renin inhibitors. In addition, we demonstrated our FBDD strategy integrating highly sensitive biochemical assay, X-ray crystallography, and high-throughput synthesis and in silico library design aimed at fragment morphing at the initial stage was effective to elucidate a pocket profile and a promising lead compound.
PubMed: 27720325
DOI: 10.1016/j.bmc.2016.09.065
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.64 Å)
構造検証レポート
Validation report summary of 5t4s
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon